Dark
Light
System
Institutional Investment Manager
BELLEVUE ASSET MANAGEMENT AG
BELLEVUE ASSET MANAGEMENT AG (CIK: 0001642343). Institutional holdings reported to the SEC.

Institutional Holdings (2015Q3)
Portfolio Summary: 133 holdings with a total value of $613,098,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 GILEAD SCIENCES INC 254,050 24,945,000 4.07%
2 CELGENE CORP 229,760 24,853,000 4.05%
3 BIOGEN INC 71,770 20,943,000 3.42%
4 ABBOTT LABS 463,000 18,622,000 3.04%
5 REGENERON PHARMACEUTICALS 38,900 18,094,000 2.95%
6 MEDTRONIC INC 270,000 18,074,000 2.95%
7 AMGEN INC 120,000 16,598,000 2.71%
8 ILLUMINA INC 87,625 15,406,000 2.51%
9 UNITEDHEALTH GROUP INC 120,000 13,921,000 2.27%
10 ALLERGAN PLC 50,150 13,631,000 2.22%
11 STRYKER CORP 140,700 13,240,000 2.16%
12 EXPRESS SCRIPTS HLDG CO 160,000 12,954,000 2.11%
13 BECTON DICKINSON & CO 92,305 12,245,000 2.00%
14 ENDO INTL 158,000 10,946,000 1.79%
15 TEVA PHARMACEUTICAL INDS LTD 169,220 9,554,000 1.56%
16 Mylan Inc 225,000 9,059,000 1.48%
17 ZIMMER BIOMET HLDGS INC 95,500 8,970,000 1.46%
18 VERTEX PHARMACEUT 82,500 8,592,000 1.40%
19 INCYTE 77,000 8,495,000 1.39%
20 DR REDDYS LABS LTD 130,000 8,308,000 1.36%
21 LIGAND PHARMACEUTICALS INC 95,730 8,199,000 1.34%
22 CIGNA CORPORATION 58,000 7,831,000 1.28%
23 ALEXION PHARMACEUTIC 49,400 7,726,000 1.26%
24 AURIS MED HLDG AG 2,169,625 7,724,000 1.26%
25 ST JUDE 122,000 7,697,000 1.26%
26 MCKESSON CORP 41,000 7,586,000 1.24%
27 JAZZ PHARMACEUTICALS PLC SHS USD 56,000 7,437,000 1.21%
28 COMMUNITY HEALTH SYS INC NEW COM 162,340 6,943,000 1.13%
29 BIOMARIN 65,000 6,846,000 1.12%
30 KITE PHARMA INCORPORATED 119,500 6,654,000 1.09%
31 BOSTON SCIENTIFIC CORP 400,000 6,564,000 1.07%
32 SHIRE PLC 30,890 6,340,000 1.03%
33 EDWARDS LIFESCIENCES CORP 44,500 6,327,000 1.03%
34 PERRIGO CO PLC 40,000 6,291,000 1.03%
35 INTUITIVE SURGICAL INC 13,550 6,227,000 1.02%
36 CARDINAL HEALTH INC 80,000 6,146,000 1.00%
37 INSYS THERAPEUTICS INC NEW COM NEW 210,000 5,977,000 0.97%
38 AETNA INC NEW 53,000 5,799,000 0.95%
39 CENCORA 60,000 5,699,000 0.93%
40 HUMANA 30,000 5,370,000 0.88%
41 IONIS PHARMACEUTICAL 132,000 5,335,000 0.87%
42 CVS HEALTH CORP 55,000 5,306,000 0.87%
43 MALLINCKRODT PUB LTD CO SHS 80,000 5,115,000 0.83%
44 CLOVIS ONCOLOGY INC 55,000 5,058,000 0.82%
45 Intersect ENT Inc 199,777 4,675,000 0.76%
46 TENET HEALTHCARE CORP 126,510 4,671,000 0.76%
47 JOHNSON & JOHNSON 50,000 4,668,000 0.76%
48 COHERUS BIOSCIENCES INC COM 230,000 4,609,000 0.75%
49 BARD C R INC 24,500 4,565,000 0.74%
50 SUPERNUS PHARMACEUTICALS INC COM 320,000 4,490,000 0.73%
Page 1 of 3

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-011338, filed 2015.11.12).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.